Evidence map›Paper›PMID 42402159›Full record

ArticleBiotechnology and bioengineering2026

Revisiting the Carbon Footprint of Single-Use Technologies in Biomanufacturing: A Bottom-Up Analysis Reveals a Paradigm Shift.

Jan Reiners, Katharina Bruno-Thakur, Daina Romeo, Weronika Kuśmierczyk, Ferdinand Stückler

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jan ReinersRoche Diagnostics GmbH, Penzberg, Germany.ORCID https://orcid.org/0009-0001-3294-0916
Katharina Bruno-ThakurF. Hoffmann-La Roche Ltd., Basel, Switzerland.
Daina RomeoF. Hoffmann-La Roche Ltd., Basel, Switzerland.
Weronika KuśmierczykLonza, Basel, Switzerland.
Ferdinand StücklerRoche Diagnostics GmbH, Penzberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biopharmaceutical industry increasingly relies on single-use technologies (SUT) for operational flexibility. For a long time, SUT was considered more sustainable than stainless-steel (SST) systems due to water and energy savings. This study re-evaluates this paradigm via a detailed bottom-up analysis of the SUT carbon footprint at the 2000 L scale. Our analysis, based on two real-world facility case studies (a full-SUT and a hybrid-SUT model), shows that the CO2 footprint of SUT is significantly higher than previously assumed. This granular analysis, based on physical disassembly and updated "cradle-to-gate" factors, identifies filters and bags as key emission hotspots. A separate comparative analysis also shows that key SST process steps-favored by the progressive decarbonization of electricity grids-can now have a lower carbon footprint than their SUT counterparts. Our data demonstrates that an operationally optimized hybrid facility design, which combines SUT with SST, can significantly reduce plastic waste and associated emissions. These findings compel a reassessment of sustainability strategies in biopharmaceutical manufacturing and highlight the potential of fit-for-purpose hybrid models as an effective lever for reducing the ecological footprint.

Indexed as

BiotechnologyCarbon FootprintCarbon DioxideCarbon Dioxidebiotechnologymathematical modelprocessingsingle‐use technologysustainabilityunit operations

Identifiers

PMID42402159
PMCPMC13576860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.